Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study

Florent Huang¹, Lucas Rémi Khellaf², Guillaume Lefèvre³, Alvise Berti⁴, Thomas d'Humières⁵, Alessandro Sionis⁶, Albert Ariza Solé⁷, Federica Bello⁸, Juan Andres Bermeo Garrido⁷, Etienne Crickx⁹, Paolo Delvino¹⁰, Giacomo Emmi¹¹, Antoine Gaillet¹², Gilles Garcia¹³, Pierre-Edouard Gavand¹⁴, Jean-Louis George¹⁵, Floriane Gilles¹⁵, Cécile Golden¹⁶, Pascal de Groote¹⁷, Aurélien Guffroy¹⁸, Nihal Martis¹⁹, Sara Monti²⁰, Pierre Mourlanette²¹, Marc Pineton de Chambrun²², Fabrice Prunier²³, Francesca Regola²⁴, Gabriel Seret²⁵, Benjamin Terrier²⁶, Ludovic Tréfond²⁷, Géraud Souteyrand²⁸, Olivier Varenne²⁵, Filippo Zilio²⁹, Franck Haziza³⁰, Hakim Benamer³⁰, Jean-Emmanuel Kahn³¹, Alexandre Vallée³², Matthieu Groh³³; French National Reference Center for Hypereosinophilic Syndromes and European EGPA Study Groups

Affiliations

¹ ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France.
² French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France.
³ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France; Inserm U1286 Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.
⁴ Center for Medical Sciences, Department of Cellular, Computational, and Integrative Biology, University of Trento, Trento, Italy; Rheumatology Unit, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Trento, Trento, Italy.
⁵ Physiology Department, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
⁶ Intensive Cardiac Care Unit, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
⁷ Intensive Cardiac Care Unit, Cardiology Department, Bellvitge University Hospital, Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
⁸ Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy; Interdisciplinary Internal Medicine Unit, Behçet Centre and Lupus Clinic, AOU Careggi Hospital of Firenze, Firenze, Italy.
⁹ Internal Medicine Department, Centre National de Référence des Cytopénies Auto-immunes de l'Adulte, Hôpital Henri Mondor, Fédération Hospitalo-Universitaire Innovative Therapy for Immune Disorders, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, Créteil, France.
¹⁰ Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy; Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
¹¹ Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy; Interdisciplinary Internal Medicine Unit, Behçet Centre and Lupus Clinic, AOU Careggi Hospital of Firenze, Firenze, Italy; Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash University, Clayton, Victoria, Australia.
¹² French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Medical Intensive Care Unit, Hôpitaux Universitaires Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
¹³ Department of Pulmonology, Antony Private Hospital, Antony, France.
¹⁴ Internal Medicine, Clinique Rhéna, Strasbourg, France.
¹⁵ Department of Cardiology, Centre Hospitalier de Versailles, André Mignot Hospital, Le Chesnay-Rocquencourt, France.
¹⁶ Internal Medicine, Vesoul Hospital, Vesoul, France.
¹⁷ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; CHU Lille, Service de Cardiologie, Lille, France; Inserm U1167, Institut Pasteur de Lille, Lille, France.
¹⁸ Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (CNR RESO), Tertiary Center for Primary Immunodeficiencies, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
¹⁹ Internal Medicine Department, Hôpital de Larchet, University Hospital of Nice, Côte d'Azur University, Nice, France.
²⁰ Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy.
²¹ Clinique des Cèdres, Château Alliez, Cornebarrieu, France.
²² Department of Intensive Care Medicine, APHP, Sorbonne Université, Pitié Salpétrière, Paris, France.
²³ Department of Cardiology, Universitary Hospital of Angers, Angers, France.
²⁴ Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy.
²⁵ Department of Cardiology, University of Sorbonne-Paris Cité, APHP, Cochin Hospital, Paris, France.
²⁶ Department of Internal Medicine, Hôpital Cochin, APHP, Paris, France.
²⁷ Internal Medicine, Gabriel Montpied Hospital, Clermond-Ferrand, France.
²⁸ Department of Cardiology, Gabriel Montpied Hospital, Clermond-Ferrand, France.
²⁹ Department of Cardiology, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Trento, Trento, Italy.
³⁰ ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France.
³¹ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
³² Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France.
³³ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France. Electronic address: m.groh@hopital-foch.com.

PMID: 38307204
DOI: 10.1016/j.jaip.2024.01.036

Multicenter Study

Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study

Florent Huang et al. J Allergy Clin Immunol Pract. 2024 May.

. 2024 May;12(5):1377-1381.e2.

doi: 10.1016/j.jaip.2024.01.036. Epub 2024 Feb 1.

Authors

Affiliations

¹ ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France.
² French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France.
³ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France; Inserm U1286 Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.
⁴ Center for Medical Sciences, Department of Cellular, Computational, and Integrative Biology, University of Trento, Trento, Italy; Rheumatology Unit, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Trento, Trento, Italy.
⁵ Physiology Department, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
⁶ Intensive Cardiac Care Unit, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
⁷ Intensive Cardiac Care Unit, Cardiology Department, Bellvitge University Hospital, Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
⁸ Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy; Interdisciplinary Internal Medicine Unit, Behçet Centre and Lupus Clinic, AOU Careggi Hospital of Firenze, Firenze, Italy.
⁹ Internal Medicine Department, Centre National de Référence des Cytopénies Auto-immunes de l'Adulte, Hôpital Henri Mondor, Fédération Hospitalo-Universitaire Innovative Therapy for Immune Disorders, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, Créteil, France.
¹⁰ Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy; Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
¹¹ Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy; Interdisciplinary Internal Medicine Unit, Behçet Centre and Lupus Clinic, AOU Careggi Hospital of Firenze, Firenze, Italy; Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash University, Clayton, Victoria, Australia.
¹² French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Medical Intensive Care Unit, Hôpitaux Universitaires Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
¹³ Department of Pulmonology, Antony Private Hospital, Antony, France.
¹⁴ Internal Medicine, Clinique Rhéna, Strasbourg, France.
¹⁵ Department of Cardiology, Centre Hospitalier de Versailles, André Mignot Hospital, Le Chesnay-Rocquencourt, France.
¹⁶ Internal Medicine, Vesoul Hospital, Vesoul, France.
¹⁷ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; CHU Lille, Service de Cardiologie, Lille, France; Inserm U1167, Institut Pasteur de Lille, Lille, France.
¹⁸ Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (CNR RESO), Tertiary Center for Primary Immunodeficiencies, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
¹⁹ Internal Medicine Department, Hôpital de Larchet, University Hospital of Nice, Côte d'Azur University, Nice, France.
²⁰ Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy.
²¹ Clinique des Cèdres, Château Alliez, Cornebarrieu, France.
²² Department of Intensive Care Medicine, APHP, Sorbonne Université, Pitié Salpétrière, Paris, France.
²³ Department of Cardiology, Universitary Hospital of Angers, Angers, France.
²⁴ Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy.
²⁵ Department of Cardiology, University of Sorbonne-Paris Cité, APHP, Cochin Hospital, Paris, France.
²⁶ Department of Internal Medicine, Hôpital Cochin, APHP, Paris, France.
²⁷ Internal Medicine, Gabriel Montpied Hospital, Clermond-Ferrand, France.
²⁸ Department of Cardiology, Gabriel Montpied Hospital, Clermond-Ferrand, France.
²⁹ Department of Cardiology, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Trento, Trento, Italy.
³⁰ ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France.
³¹ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
³² Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France.
³³ French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France. Electronic address: m.groh@hopital-foch.com.

PMID: 38307204
DOI: 10.1016/j.jaip.2024.01.036

No abstract available

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study

Affiliations

Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study

Authors

Affiliations

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical